Being Sixty-Seven and Afraid of Death
I enrolled in a clinical trial not because I was dying but because I was afraid of dying.
I've been a lawyer for thirty-five years — good at logic, uncomfortable with ambiguity, skilled at managing my emotional responses. The prospect of death has been a steady background terror for most of my adult life.
I enrolled in the trial after reading about the Johns Hopkins cancer study. I don't have cancer. But the trial was for healthy older adults with death anxiety, and I qualified.
The session: I was on a reclining couch with eyeshades. The guides were quiet presences in chairs nearby. For the first two hours I experienced mostly visual phenomena — complex, beautiful, occasionally unsettling. Then there was something I don't know how to describe accurately.
I was not afraid.
I was somewhere that the question of fear about death couldn't be asked because the premise of the question — that there is a self continuous enough to be threatened — felt uncertain. Not absent, but uncertain in a way that was not terrifying but liberating.
I spent what felt like a long time in that place. When I came back, I cried — not from grief but from something that felt like relief.
The fear is not gone. I want to be honest about that. But it has a different quality now — less of a presence and more of an occasional weather. I know that the thing I was afraid of is not what I thought it was.
More Experience Reports
Three years of talk therapy, one psilocybin session, and a fundamentally different relationship with anxiety. A first-timer's account of a licensed Oregon session.
Read →What happens when you underestimate a potent strain. A first-person account of a difficult experience, how the STOP protocol made the difference, and what emerged from the center of it.
Read →A Marine veteran with treatment-resistant PTSD reflects 60 days after participating in a university psilocybin clinical trial. The session didn't cure anything. But the relationship changed.
Read →